Company Algeta ASA Xetra
Equities
GJ9
NO0010239437
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
2014 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
2014 | Actavis : M&A frenzy in healthcare sector | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,924,985 | 793,344 ( 1.806 %) | 0 | 1.806 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-1.52% | 104B | |
+6.61% | 97.47B | |
+5.71% | 22.25B | |
-12.95% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.82% | 16.36B | |
+8.13% | 14.39B | |
+37.06% | 12.37B |
- Stock Market
- Equities
- ALGETA Stock
- GJ9 Stock
- Company Algeta ASA